solifenacin succinate tablets Archives - CDR

Camber Pharmaceuticals launches generic Vesicare

September 28, 2022 by Chain Drug Review Camber, solifenacin succinate tablets Pharmacy, Supplier News

PISCATAWAY, N.J. – Camber Pharmaceuticals announced the addition of solifenacin succinate tablets to its current portfolio. Solifenacin succinate tablets are used to treat symptoms of overactive bladder, such as frequent or urgent urination, and incontinence (urine leakage). Solifenacin succinate tablets from Camber are available in 5 mg and 10 mg strengths. Both strengths are available

Glenmark gets FDA’s nod for generic Vesicare

May 21, 2019 by Chain Drug Review Astellas Pharma’s Vesicare tablets, Glenmark Pharmaceuticals, solifenacin succinate tablets Pharmacy, Supplier News

BALTIMORE — Glenmark Pharmaceuticals has gotten the okay from the Food and Drug Administration for solifenacin succinate tablets, in 5 mg and 10 mg dosages strengths. Solifenacin succinate tablets are the generic of Astellas Pharma’s Vesicare tablets, 5 mg and 10 mg. The product had a market value of roughly $942.7 million for the 12